cetylpyridinium chloride anhydrous has been researched along with norethindrone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, G; Scott, I; Worrall, A | 1 |
| Finger, WR | 1 |
| Wang, M; Xiao, B | 1 |
| Maclennan, AH | 1 |
| Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C | 1 |
| Christodoulakos, G; Creatsa, M; Kaparos, G; Karaflou, M; Lambrinoudaki, I; Rizos, D | 1 |
2 trial(s) available for cetylpyridinium chloride anhydrous and norethindrone
| Article | Year |
|---|---|
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.
Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners | 2010 |
Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.
Topics: Androstenes; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Progestins | 2010 |
6 other study(ies) available for cetylpyridinium chloride anhydrous and norethindrone
| Article | Year |
|---|---|
Is norethisterone a lifestyle drug? Health is not merely the absence of disease.
Topics: Contraceptives, Oral, Synthetic; Female; Health; Humans; Menstruation Disturbances; Norethindrone; Patient Satisfaction; Practice Patterns, Physicians' | 2000 |
ON 7/7/7 is first choice for 60% of CTU survey respondents.
Topics: Americas; Behavior; Biology; Commerce; Community Health Workers; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Costs and Cost Analysis; Decision Making; Delivery of Health Care; Developed Countries; Developing Countries; Economics; Endocrine System; Family Planning Services; Health; Health Personnel; Health Planning; Hormones; Levonorgestrel; Marketing of Health Services; Norethindrone; North America; Physicians; Physiology; United States | 1987 |
Progestin-only injectables offer many advantages.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Health; Injections; Medroxyprogesterone Acetate; Norethindrone; Public Health; Safety | 1995 |
Birth control techniques in China.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Anesthesia; Asia; Asia, Eastern; Chemosterilants; China; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptives, Oral; Delivery of Health Care; Developing Countries; Economics; Family Planning Services; Gossypol; Health; Health Services; Hormones; Injections; Intrauterine Devices; Medicine; Megestrol Acetate; Norethindrone; Plants, Medicinal; Postpartum Period; Pregnancy Rate; Prostaglandins; Quinestrol; Reproductive Control Agents; Research; Spermatogenesis-Blocking Agents; Sterilization, Reproductive; Sterilization, Tubal; Technology; Vacuum Curettage; Vasectomy | 1983 |
Oral contraceptives.
Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases | 1987 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |